AbCellera Biologics Inc. (ABCL)

AbCellera Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	873	1,657	2,898	4,027	10,702	-
Market Cap Growth	-38.86%	-42.83%	-28.02%	-62.37%	-	-
Enterprise Value	218	943	2,063	3,315	10,112	-1
PE Ratio	-	-11.32	18.28	26.24	89.99	-
PS Ratio	24.40	43.57	5.97	10.73	45.90	-
PB Ratio	0.77	1.44	2.35	3.93	12.89	-
P/FCF Ratio	-10.39	-13.71	14.02	21.63	822.15	-
P/OCF Ratio	-31.94	-37.76	10.45	16.46	471.66	-
EV/Sales Ratio	6.10	24.79	4.25	8.84	43.37	-0.13
EV/EBITDA Ratio	-4.86	-6.58	7.58	14.02	59.51	9.47
EV/EBIT Ratio	-3.98	-5.42	8.63	15.13	61.41	0.73
EV/FCF Ratio	-5.26	-7.80	9.98	17.81	776.79	1.13
Debt / Equity Ratio	0.06	0.06	0.06	0.04	0.00	0.59
Debt / EBITDA Ratio	-0.49	-0.50	0.28	0.15	0.02	-39.26
Debt / FCF Ratio	-0.53	-0.59	0.37	0.20	0.29	-4.67
Quick Ratio	7.22	6.86	8.03	7.53	7.80	1.37
Current Ratio	7.76	7.33	8.67	7.71	7.86	1.60
Asset Turnover	0.02	0.03	0.31	0.32	0.45	0.52
Interest Coverage	-	-	-	-	24.17	-9.58
Return on Equity (ROE)	-12.60%	-12.40%	12.90%	15.70%	28.30%	-20.20%
Return on Assets (ROA)	-9.80%	-9.70%	10.10%	12.90%	23.10%	-9.80%
Return on Capital (ROIC)	-18.97%	-19.39%	10.96%	13.48%	14.09%	-25.20%
Earnings Yield	-16.82%	-8.84%	5.47%	3.81%	1.11%	-
FCF Yield	-14.61%	-7.29%	7.13%	4.62%	0.12%	-
Buyback Yield / Dilution	-1.72%	8.15%	1.09%	-20.96%	-73.88%	11.68%
Total Shareholder Return	-1.72%	8.15%	1.09%	-20.96%	-73.88%	11.68%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).